Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases

摘要

The present invention refers to an oligonucleotide for use in prophylaxis and/or treatment of a TGF-beta1 and TGF-beta 2 mRNA overexpressing tumor, a TGF-beta2 and TGF-beta3 mRNA overexpressing tumor, a TGF-beta1 and TGF-beta3 mRNA overexpressing tumor, or a TGF-beta1, TGF-beta 2, and TGF-beta3 mRNA overexpressing tumor.